Icahn School of Medicine at Mount Sinai
New York, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Atopic dermatitis (eczema)
FollowWhat is new in Atopic dermatitis (eczema) research, which clinical trials are open, and who works on it. From public registries and PubMed, with the source and date of every fact.
Cure status
- AbrocitinibPhase 3 · NCT06807268 · NCT07823595 · NCT06807281
- DupilumabPhase 3 · NCT07783425
- EpiCeramPhase 3 · NCT03667651
- LebrikizumabPhase 3 · NCT06526182 · NCT07542483 · NCT05735483 · NCT07873801 · NCT05559359
- MG-K10 Humanized Monoclonal Antibody InjectionPhase 3 · NCT07479615
- Roflumilast Cream 0.3%Phase 3 · NCT07916480
- TilrekimigPhase 3 · NCT07765888 · NCT07783425
- Topical Corticosteroid (TCS)Phase 3 · NCT05559359
- Vehicle CreamPhase 3 · NCT07916480
- GX-03Phase 2/3 · NCT07355075
- herbal ointmentPhase 2/3 · NCT06850311
- ADX-914Phase 2 · NCT05509023
- ATI-045Phase 2 · NCT07011706
- BarzolvolimabPhase 2 · NCT06727552
- BFB759Phase 2 · NCT07105488
- CamoteskimabPhase 2 · NCT07599813
- CephalexinPhase 2 · NCT01631617
- DoxycyclinePhase 2 · NCT01631617
- Experimental: Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]Phase 2 · NCT04600362
- Fluticasone propionate Cream 0.05%Phase 2 · NCT03742414
- GHZ339Phase 2 · NCT06947993
- IMG-007Phase 2 · NCT07734415 · NCT07037901
- Matching placeboPhase 2 · NCT06727552
- PF-07264660Phase 2 · NCT05995964
- PF-07275315Phase 2 · NCT05995964
- PF-08049820Phase 2 · NCT07216027
- Roseomonas mucosa (RSM2015) and Cardamom seedsPhase 2 · NCT06096857
- SoquelitinibPhase 2 · NCT07441395
- TAVO101Phase 2 · NCT06176040
- Tri-lipid skin barrier cream (Epiceram)Phase 2 · NCT03742414
- Triamcinolone (TAC) 0.1% creamPhase 2 · NCT06994520
- Trimethoprim/sulfamethoxazole (TMP/SMZ)Phase 2 · NCT01631617
- zabalafinPhase 2 · NCT06855745
- ARQ-234Phase 1 · NCT07453602
- Clobetasol OintmentPhase 1 · NCT06504160
- DCY636Phase 1 · NCT07604324
- Fluocinonide OintmentPhase 1 · NCT06504160
- Hydrocortisone OintmentPhase 1 · NCT06504160
- Onabotulinum Toxin Type A - Phase 1bPhase 1 · NCT06928246
- Onabotulinum Toxin Type A - Phase 2Phase 1 · NCT06928246
- REGN20423Phase 1 · NCT07527923
- ShA9 Topical GelPhase 1 · NCT06504160
- Triamcinolone OintmentPhase 1 · NCT06504160
Closest to patients
- A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic DermatitisA Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic DermatitisCentrum Badan Klinicznych PI-House sp. z o.o. · Gdansk, Poland + 91 more hospitalsPhase 3Results expected 2026
- VItamin D in pregnanCy for prevenTion Of eaRlY Childhood AsthmaVItamin D in pregnanCy for prevenTion Of eaRlY Childhood AsthmaCopenhagen University Hospital of Copenhagen · Gentofte Municipality, DenmarkPhase 3Results expected 2026
- Fish Oil in pREgnancY for Personalized Prevention of Early Childhood AsthmaFish Oil in pREgnancY for Personalized Prevention of Early Childhood AsthmaCopenhagen University Hospital of Copenhagen · Gentofte Municipality, DenmarkPhase 3Results expected 2026
Choose one to continue
Apply for experimental treatment or a research study
The trial team decides who can take part; your doctor can help you ask.
Distance is calculated in your browser. Your city is not sent to us.
Loading trial sites…
Latest news
Results, new trials and publications, newest first. Every item links to its source.
Results and new studies, newest first, in plain words.
Plain-language summary pending. Original title shown.
Publication
Pharmacokinetics, efficacy and safety of dupilumab administered with prefilled pen devices in patients aged <12 years with atopic dermatitis.
Pharmacokinetics, efficacy and safety of dupilumab administered with prefilled pen devices in patients aged <12 years with atopic dermatitis.
British journal of clinical pharmacology
PubMed · PMID 42980500Publication
Development and evaluation of a microneedle-assisted transdermal delivery system for compound betamethasone in atopic dermatitis.
Development and evaluation of a microneedle-assisted transdermal delivery system for compound betamethasone in atopic dermatitis.
Drug delivery and translational research
PubMed · PMID 42981018Case report
Case Report: Dupilumab-associated psoriasiform eruption followed by depigmentation in a patient with prurigo nodularis and Vogt-Koyanagi-Harada disease.
Case Report: Dupilumab-associated psoriasiform eruption followed by depigmentation in a patient with prurigo nodularis and Vogt-Koyanagi-Harada disease.
Frontiers in immunology
PubMed · PMID 42984631
Organisations that can help
Helplines, patient groups and support services for you and your family.
International & European
European Federation of Allergy and Airways Diseases Patients' Associations
Federation of national allergy, asthma and COPD patient associations: AboutAsthma.org patient guide, patient academy, expert patient network, EU advocacy.
Visit site: European Federation of Allergy and Airways Diseases Patients' AssociationsEuropean Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
Visit site: European Patients' Forum (EPF)International Alliance of Dermatology Patient Organizations (GlobalSkin)
Global alliance of dermatology patient organisations across many skin diseases; research (e.g. global patient surveys), advocacy and capacity building for member groups.
Visit site: International Alliance of Dermatology Patient Organizations (GlobalSkin)International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Visit site: International Alliance of Patients' Organizations
Frontlight is not affiliated with these organisations; we list them because they help.
Checked automatically every 90 days.
Find fellow researchers
Groups with active Atopic dermatitis (eczema) work.
Northwestern University
Evanston, United States
Team details appear once the team leader joins.
Is this your team? Claim it
George Washington University
Washington, United States
Team details appear once the team leader joins.
Is this your team? Claim it
University of California San Diego
San Diego, United States
Team details appear once the team leader joins.
Is this your team? Claim it
University of Toronto
Toronto, Canada
Team details appear once the team leader joins.
Is this your team? Claim it
Regeneron (United States)
Tarrytown, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Oregon Health & Science University
Portland, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Harvard University
Cambridge, United States
Team details appear once the team leader joins.
Is this your team? Claim it
King's College London
London, United Kingdom
Team details appear once the team leader joins.
Is this your team? Claim it
Probity Medical Research
Waterloo, Canada
Team details appear once the team leader joins.
Is this your team? Claim it
University of California, San Francisco
San Francisco, United States
Team details appear once the team leader joins.
Is this your team? Claim it
University Hospital Schleswig-Holstein
Kiel, Germany
Team details appear once the team leader joins.
Is this your team? Claim it